Do your research! Play the TA. All posts are my opinion.
Is fundamental trading dead?
"We hope not." Richard Dennis
Recent LXRX News
- Lexicon Pharmaceuticals Resubmits Sotagliflozin NDA for Type 1 Diabetes • GlobeNewswire Inc. • 06/21/2024 12:00:00 PM
- Data From Lexicon’s RELIEF-DPN 1 Phase 2 Study of LX9211 Published Today in Diabetes Care, a Peer-Reviewed Journal of the American Diabetes Association • GlobeNewswire Inc. • 06/19/2024 12:00:00 PM
- Analysis of INPEFA® (Sotagliflozin) Cost-Effectiveness Published in JACC: Heart Failure, the Peer-Reviewed Journal of the American College of Cardiology • GlobeNewswire Inc. • 06/18/2024 12:00:00 PM
- Findings on the Burdens of Diabetic Peripheral Neuropathic Pain (DPNP) Among Three Lexicon-Sponsored Presentations at the 84th Scientific Sessions of the American Diabetes Association • GlobeNewswire Inc. • 06/14/2024 12:00:00 PM
- Lexicon Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference 2024 • GlobeNewswire Inc. • 05/29/2024 11:30:00 AM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 05/16/2024 04:15:16 AM
- Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend] • Edgar (US Regulatory) • 05/14/2024 09:05:01 PM
- New Post-Hoc Analysis of Pooled Phase 3 Data Shows That INPEFA® (Sotagliflozin) Reduced Risk of Heart Failure Events in Patients With Preserved Ejection Fraction • GlobeNewswire Inc. • 05/14/2024 11:00:00 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:05:26 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:04:41 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:03:08 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:01:32 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 05/13/2024 08:00:44 PM
- Form S-3/A - Registration statement under Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 05/10/2024 09:14:29 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 05/10/2024 08:15:54 PM
- Lexicon Pharmaceuticals to Participate in the Bank of America Securities Healthcare Conference 2024 • GlobeNewswire Inc. • 05/09/2024 11:30:00 AM
- Lexicon Pharmaceuticals Reports First Quarter 2024 Financial Results and Provides Business Update • GlobeNewswire Inc. • 05/02/2024 08:05:00 PM
- Lonnel Coats Retires as Chief Executive Officer and Board Member of Lexicon Pharmaceuticals • GlobeNewswire Inc. • 04/29/2024 01:00:00 PM
- Lexicon Pharmaceuticals to Host First Quarter 2024 Financial Results Conference Call and Webcast on May 2, 2024 • GlobeNewswire Inc. • 04/29/2024 11:00:00 AM
- Lexicon Pharmaceuticals to Host 2024 Investor Day • GlobeNewswire Inc. • 04/18/2024 12:00:40 PM
- Lexicon Pharmaceuticals to Participate in the 23rd Annual Needham Virtual Healthcare Conference • GlobeNewswire Inc. • 04/03/2024 12:00:00 PM
- Clinical Data on the Impact of Sotagliflozin on Stroke and Heart Attack Risk Among Four Lexicon-Sponsored Presentations at the American College of Cardiology 73rd Annual Scientific Session & Expo • GlobeNewswire Inc. • 03/25/2024 01:20:45 PM
- New Post Hoc Analysis of inTandem3 Study Demonstrates Improvements In Glycemic Control With Sotagliflozin Treatment in Patients With Type 1 Diabetes and Chronic Kidney Disease • GlobeNewswire Inc. • 03/12/2024 12:00:00 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 03/11/2024 08:25:55 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/11/2024 11:26:32 AM
Glidelogic Corp. Becomes TikTok Shop Partner, Opening a New Chapter in E-commerce Services • GDLG • Jul 5, 2024 7:09 AM
Freedom Holdings Corporate Update; Announces Management Has Signed Letter of Intent • FHLD • Jul 3, 2024 9:00 AM
EWRC's 21 Moves Gaming Studios Moves to SONY Pictures Studios and Green Lights Development of a Third Upcoming Game • EWRC • Jul 2, 2024 8:00 AM
BNCM and DELEX Healthcare Group Announce Strategic Merger to Drive Expansion and Growth • BNCM • Jul 2, 2024 7:19 AM
NUBURU Announces Upcoming TV Interview Featuring CEO Brian Knaley on Fox Business, Bloomberg TV, and Newsmax TV as Sponsored Programming • BURU • Jul 1, 2024 1:57 PM
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM